About
Healthcare providers desperately need to reduce spend on “super-utilizers”, the 5% of patients who account for 50% of healthcare budgets. This is driven by severe workforce shortage, post-pandemic backlogs and a long-term shift towards value-based healthcare. Feebris’ AI-guided software platform is used by health providers to enable non-clinicians to conduct clinical examinations, improving early detection and reducing hospital visits at scale. Feebris is the only company that provides clinical-grade data across the continuum of care, agnostic of hardware and without connectivity. Feebris has helped health providers target super-utilizer patient groups, delivering 7-13x ROI. The platform is used across 100+ NHS sites, covering elderly care facilities, primary care & community nursing programs.
Key Facts
5X reduction in time to diagnosis, 88% reduction in false alarms, 35% reduction in hospitalizations. Live in 100+ NHS & social care sites in the UK and in multiple states in the US.
Successes in UK/NHS
The platform is used across 100+ NHS sites, covering elderly care facilities, primary care & community nursing programs. Feebris has helped health provider deliver proactive care for the most vulnerable patients, delivering 7-13x ROI. An alumnus of the DH.London and the NIA Innovation Accelerators, Feebris has also been named Innovator of the Year by Giant Health, Best Investment in Disruptive Technology by UKBAA and HealthTech Top 50 companies by Business Cloud.Company details
Solutions
Delivering advanced patient care
Providing advanced screening and diagnostics
Specialism
Long-term condition monitoring
Primary Care Screening
Specialised diagnostics
Company details
Want to connect with this innovator?
Make an enquiryWebsite
www.feebris.comMarkets already exporting to
USA
Desired Markets
USA
Desired customer types
health systems (public & private) and health payors (insurers/plans)